blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP4234720

EP4234720 - EPIGENETIC BIOMARKERS FOR THE DIAGNOSIS OF THYROID CANCER [Right-click to bookmark this link]
StatusThe application is deemed to be withdrawn
Status updated on  05.07.2024
Database last updated on 11.09.2024
FormerThe application has been published
Status updated on  28.07.2023
Most recent event   Tooltip05.07.2024Application deemed to be withdrawnpublished on 07.08.2024  [2024/32]
Applicant(s)For all designated states
Consejo Superior de Investigaciones Cientificas
Serrano, 117
28006 Madrid / ES
For all designated states
Fundacion Para La Investigacion e Innovacion Biosanitaria Principado de Asturias
Avenida de Roma s/n
33011 Oviedo / ES
[2023/35]
Inventor(s)01 / Rodríguez-Rodero, Sandra
28006 Madrid / ES
02 / Tejedor Vaquero, Juan Ramón
28006 Madrid / ES
03 / Fernández Fernández, Agustín
28006 Madrid / ES
04 / Fernández Fraga, Mario
28006 Madrid / ES
05 / Delgado Álvarez, Elías
33011 Oviedo (ASTURIAS) / ES
06 / Morales Sánchez, Paula
33011 Oviedo (ASTURIAS) / ES
07 / Menendez Torre, Edelmiro
33011 Oviedo (ASTURIAS) / ES
 [2023/35]
Representative(s)Pons
Glorieta Rubén Darío 4
28010 Madrid / ES
[2023/35]
Application number, filing date22382165.325.02.2022
[2023/35]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report 
No.:EP4234720
Date:30.08.2023
Language:EN
[2023/35]
Search report(s)(Supplementary) European search report - dispatched on:EP17.08.2022
ClassificationIPC:C12Q1/6886
[2023/35]
CPC:
C12Q1/6886 (EP); C12Q2600/118 (EP); C12Q2600/154 (EP)
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2023/35]
Extension statesBANot yet paid
MENot yet paid
Validation statesKHNot yet paid
MANot yet paid
MDNot yet paid
TNNot yet paid
TitleGerman:EPIGENETISCHE BIOMARKER ZUR DIAGNOSE VON SCHILDDRÜSENKREBS[2023/35]
English:EPIGENETIC BIOMARKERS FOR THE DIAGNOSIS OF THYROID CANCER[2023/35]
French:BIOMARQUEURS ÉPIGÉNÉTIQUES POUR LE DIAGNOSTIC DU CANCER DE LA THYROÏDE[2023/35]
Examination procedure01.03.2024Application deemed to be withdrawn, date of legal effect  [2024/32]
25.03.2024Despatch of communication that the application is deemed to be withdrawn, reason: examination fee not paid in time  [2024/32]
Fees paidPenalty fee
Additional fee for renewal fee
29.02.202403   M06   Not yet paid
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Documents cited:Search[A]EP1942197  (EPIGENOMICS AG [DE]) [A] 1* SEQ ID NO:27766 from Patent EP1942197 comprises SEQ ID NO:3 of the present application *;
 [I]WO2020204457  (CATHOLIC UNIV KOREA IND ACADEMIC COOPERATION FOUNDATION [KR], et al) [I] 1-14 * claim 1 *;
 [A]  - ABDUL A QURESHI ET AL, "Genomic differences in benign and malignant follicular thyroid tumours using 1-Mb array-comparative genomic hybridisation", EUROPEAN ARCHIVES OF OTO-RHINO-LARYNGOLOGY ; AND HEAD & NECK, SPRINGER, BERLIN, DE, (20120413), vol. 270, no. 1, doi:10.1007/S00405-012-2017-4, ISSN 1434-4726, pages 325 - 335, XP035157649 [A] 1 * the whole document *

DOI:   http://dx.doi.org/10.1007/s00405-012-2017-4
by applicantWO2008097543
 WO2016020551
 US2017022570
    - "Analytical performance of the ThyroSeq v3 genomic classifier for cancer diagnosis in thyroid nodules", NIKIFOROVA MN et al., Cancer, John Wiley and Sons Inc., (20180000), vol. 124, pages 1682 - 90
    - ALEXANDER EK et al., "Preoperative Diagnosis of Benign Thyroid Nodules with Indeterminate Cytology", New England Journal of Medicine, (20120000), vol. 367, doi:10.1056/NEJMoa1203208, pages 705 - 15, XP055100797

DOI:   http://dx.doi.org/10.1056/NEJMoa1203208
    - "Molecular testing for miRNA, mRNA, and DNA on fine-needle aspiration improves the preoperative diagnosis of thyroid nodules with indeterminate cytology", LABOURIER E. et al., Journal of Clinical Endocrinology and Metabolism, Endocrine Society, (20150000), vol. 100, pages 2743 - 50
    - ZAFON C. et al., DNA methylation in thyroid cancer. Endocrine-Related Cancer, BioScientifica Ltd., (20190000), pages R415 - 39
    - "Comprehensive DNA Methylation Profiling Identifies Novel Diagnostic Biomarkers for Thyroid Cancer", PARK JL et al., Thyroid, Mary Ann Liebert Inc., (20200000), vol. 30, pages 192 - 203
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.